NFKB1 and cholangiocarcinoma: NF-kB and Notch1 might be upstream regulators of ABCB1 in CCA, for the observation that NF-kB and Notch1 inhibitor suppresses the expression of ABCB1and further enhances sensitivity to anticancer drugs (31, 110).